Literature DB >> 20493911

Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.

N Kiraz1, I Dag, Y Oz, M Yamac, A Kiremitci, N Kasifoglu.   

Abstract

Candida glabrata is one of the most frequent organisms isolated from superficial and invasive fungal infections, after Candida albicans. This organism also exhibits intrinsically low susceptibility to azole antifungals and treatment often fails. The microdilution method is not very practical for use in routine susceptibility testing in the clinical laboratory, thus necessitating the use of other methods. In this study, we compared the in vitro activity of five antifungal agents in three different groups (echinocandin, polyene and azole) against 50 C. glabrata isolates by broth microdilution and disk diffusion methods recommended by Clinical Laboratory Standards Institute CLSI M27-A3 and CLSI M44-A, respectively. All the isolates were susceptible to amphotericin B (100%) and 98% of the isolates were susceptible to caspofungin by the broth microdilution method. Within the azole group drugs, voriconazole was the most active followed by fluconazole and itraconazole in vitro. The highest rate of resistance was obtained against itraconazole with a high number of isolates defined as susceptible-dose dependent or resistant. Although the disk diffusion method is easy to use in clinical laboratories, it shows very poor agreement with the reference method for fluconazole and itraconazole against C. glabrata (8% and 14%, respectively).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493911     DOI: 10.1016/j.mimet.2010.05.002

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  10 in total

1.  Chromogenic medium for direct susceptibility testing of Candida spp. isolated from urine.

Authors:  Antônio Alexandre de Vasconcelos; Everardo Albuquerque Menezes; Francisco Afrânio Cunha
Journal:  Mycopathologia       Date:  2011-03-03       Impact factor: 2.574

2.  Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Authors:  Hazim O Khalifa; Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans.

Authors:  Arome Solomon Odiba; Olanrewaju Ayodeji Durojaye; Ifeoma Maureen Ezeonu; Anthony Christian Mgbeahuruike; Bennett Chima Nwanguma
Journal:  Infect Drug Resist       Date:  2022-06-17       Impact factor: 4.177

4.  Antifungal Activity and In Silico Studies on 2-Acylated Benzo- and Naphthohydroquinones.

Authors:  David Ríos; Jaime A Valderrama; Gonzalo Quiroga; Jonathan Michea; Felipe Salas; Eduardo Álvarez Duarte; Edmundo A Venegas-Casanova; Rafael Jara-Aguilar; Carlos Navarro-Retamal; Pedro Buc Calderon; Julio Benites
Journal:  Molecules       Date:  2022-05-09       Impact factor: 4.927

5.  Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.

Authors:  Ashutosh Singh; Kelley R Healey; Priyanka Yadav; Gargi Upadhyaya; Neelam Sachdeva; Smita Sarma; Anil Kumar; Bansidhar Tarai; David S Perlin; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

6.  The Composition, Antioxidant and Antibacterial Activities of Cold-Pressed and Distilled Essential Oils of Citrus paradisi and Citrus grandis (L.) Osbeck.

Authors:  Ming-Chiu Ou; Yi-Hsin Liu; Yung-Wei Sun; Chin-Feng Chan
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-22       Impact factor: 2.629

Review 7.  Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens.

Authors:  Ewa Ksiezopolska; Toni Gabaldón
Journal:  Genes (Basel)       Date:  2018-09-19       Impact factor: 4.096

8.  Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of PDR1.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Kamiar Zomorodian; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Hossein Zarrinfar; Ferry Hagen; Zahra Zare Shahrabadi; Michaela Lackner; Hossein Mirhendi; Mohammadreza Salehi; Maryam Roudbary; Weihua Pan; Markus Kostrzewa; Teun Boekhout
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

9.  Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Mohammadreza Salehi; Melike Yaşar; Tuğrul Hoşbul; Macit Ilkit; Weihua Pan; Ferry Hagen; Nazlı Arslan; Hatice Türk-Dağı; Süleyha Hilmioğlu-Polat; David S Perlin; Cornelia Lass-Flörl
Journal:  Mycoses       Date:  2020-08-05       Impact factor: 4.377

10.  Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.

Authors:  Rabiye Altinbaş; Ayşe Barış; Sümeyye Şen; Recep Öztürk; Nuri Kiraz
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.